Effect of nicorandil in patients with heart failure: a systematic review and meta-analysis.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Cardiovascular Therapeutics

• Publication date

  2014-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/1755-5922.12097PMID 25319832
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

  2014cited by this paper
• Effects of oral nicorandil therapy on sympathetic nerve activity and cardiac events in patients with chronic heart failure: subanalysis of our previous report using propensity score matching

  2013cited by this paper
• Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes

  2013cited by this paper
• Cardioprotective Effects of Nicorandil, a Mitochondrial Potassium Channel Opener against Doxorubicin‐Induced Cardiotoxicity in Rats

  2013cited by this paper
• Blunted Proarrhythmic Effect of Nicorandil in a Langendorff‐Perfused Phase‐2 Myocardial Infarction Rabbit Model

  2013cited by this paper
• Effects of intravenous nicorandil on the mid-term prognosis of patients with acute heart failure syndrome.

  2012cited by this paper
• ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012

  2012cited by this paper
• Intravenous bolus administration of nicorandil improves myocardial perfusion in patients with acute ischemic heart failure

  2012cited by this paper
• Abstract 12180: Effectiveness of Nicorandil, a K-ATP Channel Opener, Against Contrast-Induced Nephropathy After Percutaneous Coronary Intervention in Patients with Poor Renal Function

  2011cited by this paper
• The novel atherosclerosis locus at 10q11 regulates plasma CXCL12 levels.

  2011cited by this paper
• Effects of nicorandil bolus injection alone of on renal function in patients with 'Clinical Scenario 1' acute heart failure

  2011cited by this paper
• INTRAVENOUS NICORANDIL THERAPY REDUCES MATRIX METALLOPROTEINASE-2 IN PATIENTS WITH ACUTE HEART FAILURE SYNDROMES

  2011cited by this paper
• Acute effects of intravenous nicorandil on hemodynamics in patients hospitalized with acute decompensated heart failure.

  2010cited by this paper
• Efficacy and safety of nicorandil therapy in patients with acute heart failure.

  2010influential reference
• Abstract 3920: Long-Term Nicorandil Therapy Reverses Left Ventricular Remodeling in Patients With Chronic Heart Failure: A Randomized Placebo-Controlled Study

  2009cited by this paper
• The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration

  2009cited by this paper
• Acute Efficacy and Safety of Intravenous Administration of Nicorandil in Patients With Acute Heart Failure Syndromes: Usefulness of Noninvasive Echocardiographic Hemodynamic Evaluation

  2009cited by this paper
• Heart failure-related hospitalization in the U.S., 1979 to 2004.

  2008cited by this paper
• Nicorandil reduces myocardial no-reflow by protection of endothelial function via the activation of KATP channel.

  2006cited by this paper
• Nicorandil improves post-ischemic myocardial dysfunction in association with opening the mitochondrial K(ATP) channels and decreasing hydroxyl radicals in isolated rat hearts.

  2006cited by this paper
• Nicorandil regulates Bcl-2 family proteins and protects cardiac myocytes against hypoxia-induced apoptosis.

  2006cited by this paper
• Nicorandil Inhibits Serum Starvation-Induced Apoptosis in Vascular Endothelial Cells

  2005cited by this paper
• Effects of Nicorandil on Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats

  2005cited by this paper
• Is the sarcolemmal or mitochondrial K(ATP) channel activation important in the antiarrhythmic and cardioprotective effects during acute ischemia/reperfusion in the intact anesthetized rabbit model?

  2005cited by this paper
• NICORANDIL ATTENUATES NF-κB ACTIVATION, ADHESION MOLECULE EXPRESSION, AND CYTOKINE PRODUCTION IN PATIENTS WITH CORONARY ARTERY BYPASS SURGERY

  2005cited by this paper
• Comparative effects of nicorandil with isosorbide mononitrate on cardiac sympathetic nerve activity and left ventricular function in patients with ischemic cardiomyopathy.

  2005influential reference
• Nicorandil attenuates the mitochondrial Ca2+ overload with accompanying depolarization of the mitochondrial membrane in the heart

  2004cited by this paper
• Mitochondrial K ATP channel activation is important in the antiarrhythmic and cardioprotective effects of non-hypotensive doses of nicorandil and cromakalim during ischemia/reperfusion: a study in an intact anesthetized rabbit model.

  2003cited by this paper
• Cardiomyocyte mitochondrial KATP channels participate in the antiarrhythmic and antiinfarct effects of KATP activators during ischemia and reperfusion in an intact anesthetized rabbit model.

  2003cited by this paper
• Potassium channel openers protect cardiac mitochondria by attenuating oxidant stress at reoxygenation.

  2002influential reference
• Loss of Preconditioning by Attenuated Activation of Myocardial ATP-Sensitive Potassium Channels in Elderly Patients Undergoing Coronary Angioplasty

  2002cited by this paper
• Infarct size limitation by nicorandil: roles of mitochondrial K(ATP) channels, sarcolemmal K(ATP) channels, and protein kinase C.

  2002cited by this paper
• The effect of K(atp)channel activation on myocardial cationic and energetic status during ischemia and reperfusion: role in cardioprotection.

  2001cited by this paper
• Additive effects of nicorandil on coronary blood flow during continuous administration of nitroglycerin.

  2001cited by this paper
• Scavenging effect of nicorandil on free radicals and lipid peroxide in streptozotocin-induced diabetic rats.

  2000cited by this paper
• Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction.

  1999cited by this paper
• Natriuretic peptides.

  1998cited by this paper
• Comparison of the degree of hemodynamic tolerance during intravenous infusion of nitroglycerin versus nicorandil in patients with congestive heart failure.

  1997influential reference
• Comparison of hemodynamic effects and plasma cyclic guanosine monophosphate of nicorandil and nitroglycerin in patients with congestive heart failure.

  1995influential reference
• Absence of hemodynamic tolerance to nicorandil in patients with severe congestive heart failure.

  1994influential reference
• Antianginal and Anti‐Ischemic Efficacy of Nicorandil in Comparison with Isosorbide‐5‐Mononitrate and Isosorbide Dinitrate: Results from Two Multicenter, Double‐Blind, Randomized Studies with Stable Coronary Heart Disease Patients

  1992cited by this paper
• Hemodynamic and Neurohumoral Responses to Intravenous Nicorandil in Congestive Heart Failure in Humans

  1992cited by this paper
• Adenosine triphosphate-sensitive potassium channels in the cardiovascular system.

  1991cited by this paper
• Usefulness of nicorandil in congestive heart failure.

  1990cited by this paper
• Effects of nicorandil on coronary circulation and myocardial ischemia.

  1989cited by this paper
• Comparative Effects of Nicorandil, Nitroglycerin, Nicotinic Acid, and SG‐86 on the Metabolic Status and Functional Recovery of the Ischemic‐Reperfused Myocardium

  1987cited by this paper
• Effects of a New Vasodilator, Nicorandil, on Exercise‐Induced Impairment of Left Ventricular Function in Patients with Old Myocardial Infarction

  1987cited by this paper
• Effects of Nicorandil and Other Antianginal Drugs on Myocardial pH in the Ischemic Dog Heart

  1987cited by this paper

• Nicorandil Use and Health Status Outcomes in Patients with Angina Pectoris: A Prospective, Multicenter, Cohort Study (GREAT)

  2025cites this paper
• Nicorandil treatment improves survival and spatial learning in aged granulin knockout mice

  2024cites this paper
• Intravenous nicorandil for patients with acute decompensated heart failure: a meta-analysis of randomized controlled trials

  2023influential citation
• Design, synthesis, and biological evaluation of novel NO‐releasing 4‐chromanone derivatives as potential vasodilator agents

  2022cites this paper
• Hepatoprotective effect of nicorandil against acetaminophen-induced oxidative stress and hepatotoxicity in mice via modulating NO synthesis

  2022cites this paper
• Nicorandil Decreases Renal Injury in Patients With Coronary Heart Disease Complicated With Type I Cardiorenal Syndrome

  2021cites this paper
• Comparison of antiangina therapies in patients with coronary heart disease in China: study protocol for a multicentre, retrospective, hospital system-based study

  2021cites this paper
• Nicorandil, an ATP-sensitive potassium channel activation, attenuates myocardial injury in rats with ischemic cardiomyopathy

  2021cites this paper
• Role of nitric oxide donor in methotrexate-induced testicular injury via modulation of pro-inflammatory mediators, eNOS and P-glycoprotein

  2020cites this paper
• DDDT_A_195918 1389..1400

  2019cites this paper
• Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials

  2019cites this paper
• Protective Effects of Nicorandil on Cardiac Function and Left Ventricular Remodeling in a Rat Model of Ischemic Heart Failure.

  2018cites this paper
• Molecular insights into cardiomyopathies associated with desmin (DES) mutations

  2018cites this paper
• Myocardial Protective Effects of Nicorandil on Rats with Type 2 Diabetic Cardiomyopathy

  2018cites this paper
• Nesiritide Therapy Is Associated With Better Clinical Outcomes Than Dobutamine Therapy in Heart Failure

  2017cites this paper
• Nicorandil was an Effective Treatment Option for a Patient with Bland-White-Garland Syndrome

  2017cites this paper
• Decreased cardiac mortality with nicorandil in patients with ischemic heart failure

  2017cites this paper
• Doxorubicin-induced oxidative stress: The protective effect of nicorandil on HL-1 cardiomyocytes

  2017cites this paper
• Inotropic Effects of Nicorandil on Cardiac Contractility Assessed by Left Ventricular Pressure–Volume Relationship Analyses in Anesthetized Monkeys

  2017cites this paper
• Nicorandil, a Nitric Oxide Donor and ATP-Sensitive Potassium Channel Opener, Protects Against Dystrophin-Deficient Cardiomyopathy

  2016cites this paper
• What is on the horizon for improved treatments for acutely decompensated heart failure

  2016cites this paper
• Nicorandil Inhibits Cyclic Strain-Induced Interleukin-8 Expression in Human Umbilical Vein Endothelial Cells

  2016cites this paper
• Retraction. rhBNP therapy can improve clinical outcomes and reduce in-hospital mortality compared with dobutamine in heart failure patients: a meta-analysis.

  2016cites this paper
• Heart failure epidemiology and novel treatments in Japan: facts and numbers

  2016cites this paper
• Mitochondrial involvement in myocyte death and heart failure

  2016cites this paper
• rhBNP therapy can improve clinical outcomes and reduce in-hospital mortality compared with dobutamine in heart failure patients: a meta-analysis

  2015cites this paper
• Cohort Event Monitoring (CEM) of Newer Anti-anginal Drugs in Chronic Stable Angina Pectoris (CSAP) Patients in a Tertiary Care Hospital

  2015cites this paper
• Dobutamine Therapy is Associated with Worse Clinical Outcomes Compared with Nesiritide Therapy for Acute Decompensated Heart Failure: A Systematic Review and Meta-Analysis

  2015cites this paper